DOSE DENSE CHEMOTHERAPY IN HIGH RISK BREAST CANCER: TREATMENT OUTCOME & TOXICITY
Loay Mohammad Kassem;
Abstract
We compared 104 patients with high risk early breast cancer who received either (5FU-Adriamycin – Cyclophosphamide) for 6 cycles with every 21 days with 4 cycles of (Adyiamycin – Cyclophosphamide) then 4 cycles paclitaxel every 14 days. Both arms were
Other data
| Title | DOSE DENSE CHEMOTHERAPY IN HIGH RISK BREAST CANCER: TREATMENT OUTCOME & TOXICITY | Other Titles | العلاج الكيماوي المكثف لحالات سرطان الثدي عالي الخطورة: نتائج العلاج و الاعراض الجانبية | Authors | Loay Mohammad Kassem | Keywords | DOSE DENSE CHEMOTHERAPY IN HIGH RISK BREAST CANCER: TREATMENT OUTCOME & TOXICITY | Issue Date | 2010 | Description | We compared 104 patients with high risk early breast cancer who received either (5FU-Adriamycin – Cyclophosphamide) for 6 cycles with every 21 days with 4 cycles of (Adyiamycin – Cyclophosphamide) then 4 cycles paclitaxel every 14 days. Both arms were |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.